COMBINED DRUG FOR TREATING DIABETES
    3.
    发明申请
    COMBINED DRUG FOR TREATING DIABETES 审中-公开
    用于治疗糖尿病的联合药物

    公开(公告)号:US20090227493A1

    公开(公告)日:2009-09-10

    申请号:US11915734

    申请日:2006-05-26

    IPC分类号: A61K38/22 A61K31/427

    摘要: The present invention provides a pharmaceutical composition (preferably a drug for therapeutic and/or prophylactic treatment of diabetes) comprising a GLP-1 receptor agonist and the insulin resistance improving agent 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, or a pharmacologically acceptable salt thereof, in combination.

    摘要翻译: 本发明提供了包含GLP-1受体激动剂和胰岛素抵抗性改善剂5- [4-(6-甲氧基-1-甲基-1H-苯并咪唑)的药物组合物(优选用于治疗和/或预防性治疗糖尿病的药物) 苯并咪唑-2-基甲氧基)苄基]噻唑烷-2,4-二酮或其药理学上可接受的盐。